Document is current
Any future updates will be listed below
-
Authors
Seyfizadeh, Narges
Kalbermatter, David
Imhof, Thomas
Ries, Moritz
Müller, Christian
Jenner, Leonie
Blumenschein, Elisabeth
Yendrzheyevskiy, Alexandra
Grün, Frank
Moog, Kevin
Eckert, Daniel
Engel, Ronja
Diebolder, Philipp
Chami, Mohamed
Krauss, Jürgen
Schaller, Torsten
Arndt, Michaela http://orcid.org/0000-0001-9597-4112
-
Funding
Funding for this research was provided by:
Heidelberg ImmunoTherapeutics GmbH
- License Information
-
More Information
Article History
Received: 20 December 2023
Accepted: 21 May 2024
First Online: 28 May 2024
Declarations
:
: PBMC were derived from anonymous buffy coats from the DRK Blutspendedienst, Mannheim, Germany. All in vivo animal studies were in line with ethically and regulatory requirements and approvals.
: Not applicable.
: N.S., T.S., T.I., M.R., L.J., E.B., C.M., A.Y., K.M., D.E., R.E. are or were employed by Heidelberg ImmunoTherapeutics GmbH. M.A. is Chief Executive Officer of Heidelberg ImmunoTherapeutics GmbH. All other authors declare no competing interests.
